Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world by Karnam Ashok Kumar, Gundeti Sadashivudu, K V Krishnamani, Vijay Gandhi Linga, Lakshmi Srinivas Maddali, Raghunadha Rao Digumarti

Subjects: “…Metastatic renal cell carcinoma…”
Get full text

Prognostic factors influencing survival rates in elderly patients with metastatic renal cell carcinoma by D. V. Semenov, R. V. Orlova, V. I. Shirokorad, S. V. Kostritsky, P. V. Kononets

Subjects: “…metastatic renal cell carcinoma…”
Get full text

Metastatic renal cell carcinoma presenting as penile pain – A case report by Paul Gibson Murphy, Brett P. Bell

Subjects: “…Metastatic renal cell carcinoma…”
Get full text

Graph-Based Immune Checkpoint Inhibitor Response Prediction Model for Metastatic Renal Cell Carcinoma Patients by Sandra Alonso, Laura Hernandez-Lorenzo, Ignacio Duran, Cristina Rodriguez-Antona, Jesus Garcia-Donas, Jose L. Ayala

Subjects: Get full text

Total cholesterol/high-density lipoprotein cholesterol ratio is a candidate predictor of survival outcomes in patients with metastatic renal cell carcinoma by Oktay Halit Aktepe, Ozge Yetginoglu, Mehmet Sinan Akarca, Canberk Sencan, Ahmet Unal, Elif Atag, Huseyin Salih Semiz, Aziz Karaoglu, Mustafa Erman, Suayib Yalcin

Subjects: “…Metastatic renal cell carcinoma…”
Get full text

Poor risk advanced renal cell carcinoma: Outcomes from a registry in a tertiary cancer center by Anant Ramaswamy, Amit Joshi, Vanita Noronha, Vijay Patil, Arvind Sahu, Deepan R Manickam, Rushabh Kothari, Nilesh Sable, Archi Agrawal, Santosh Menon, Kumar Prabhash

Subjects: Get full text

Rare Metastatic Pathways of Renal Cell Carcinoma: Duodenal Involvement and Therapeutic Challenges by Supriya Peshin, Faizan Bashir, Nagaishwarya Moka

Subjects: Get full text

Prevalence of erectile dysfunction and its association with age in patients with metastatic renal cell carcinoma: results from a prospective multicenter study by Yulia Tishova, Ruslan Zukov, Lev Demidov, Pavel Borisov, Vladimir Kuznetsov, Valentina Leonenko, Anastasia Tarasova, Kristina Zakurdaeva, Ilya Tsimafeyeu

Subjects: Get full text

Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma by Ilya Tsimafeyeu, Alexander Sultanbaev, Daria Dubovichenko, Makhabbat Murzalina, Alexander Volkov, Rashida Orlova, Igor Utyashev, Georgy Malina, Mark Gluzman

Subjects: “…metastatic renal cell carcinoma…”
Get full text

Can Incomplete Metastasectomy Impact Renal Cell Carcinoma Outcomes? A Propensity Score Matching Analysis From a Prospective Multicenter Collaboration by Alice Dragomir, Charles Hesswani, Gautier Marcq, Alan I So, Christian Kollmannsberger, Naveen S. Basappa, Adrian Fairey, Anil Kapoor, Aly-Khan A. Lalani, Antonio Finelli, Lori A Wood, Daniel Y.C. Heng, Georg Bjarnason, Rodney H. Breau, Luke T. Lavallée, Denis Soulières, Darrel Drachenberg, Frédéric Pouliot, Simon Tanguay

Subjects: “…clear-cell metastatic renal cell carcinoma…”
Get full text

Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol by Jakob N. Henriksen, Charlotte U. Andersen, Frede Donskov, Elke Hoffmann-Lücke, Eva Greibe, Niels Fristrup

Subjects: “…Metastatic renal cell carcinoma…”
Get full text

A Case of Advanced Renal Cell Carcinoma With Concomitant Development of Multiple Endocrine Neoplasia Type 1 That Affected Treatment Progress With Immunotherapy by Masataka Abe, Yoshiyuki Miyaji, Seitetsu Sugiyama, Kiwami Tsurui, Hirofumi Morinaka, Mikako Kaifu, Hiroyuki Kadoya, Wataru Saito, Koji Yoshida, Kazumasa Komura

Subjects: Get full text

Case Report: Oral lichenoid mucositis in a patient with metastatic renal cell carcinoma undergoing treatment with pembrolizumab and axitinib by Andrew Wellen, Michael J. Pierro, Karolyn A. Wanat, Ariel A. Nelson

Subjects: Get full text

Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma by Jiwoong Yu, Hyeonju Ahn, Kyung Yeon Han, Wan Song, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Se Hoon Park, Woong‐Yang Park, Ji Hyun Lee, Minyong Kang

Subjects: Get full text

Vogt‐Koyanagi‐Harada disease‐like uveitis induced by nivolumab in metastatic renal cell carcinoma by Hitomi Imai, Tomoyuki Koguchi, Yuki Harigane, Kei Yaginuma, Satoru Meguro, Seiji Hoshi, Junya Hata, Hidenori Akaihata, Soichiro Ogawa, Yoshiyuki Kojima

Subjects: Get full text

Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patients by Jeffrey Thomas Yorio, Aviva G. Asnis-Alibozek, Vijay Kasturi, Thomas E. Hutson

Subjects: “…Metastatic renal cell carcinoma…”
Get full text

Stereotactic Ablative Radiation Therapy for Metastatic Renal Cell Carcinoma – A Review of Evidence by Hima Bora, Gautam Sarma, Partha Pratim Medhi

Subjects: Get full text

Exceptional Response in a Patient with mRCC Through Precision-Guided Treatment Involving Immunotherapy Rechallenge with Temsirolimus and Bevacizumab by Ashkan Adibi, Ünal Metin Tokat, Eylül Özgü, Şevval Nur Bilgiç, Nalan Akgül Babacan, Onur Tutar, Razelle Kurzrock, Mutlu Demiray

Subjects: “…metastatic renal cell carcinoma (mrcc)…”
Get full text

Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study by Maria T. Bourlon, Maria T. Bourlon, Luca Galli, Enrique Grande, Se Hoon Park, Bohuslav Melichar, Timothy J. Schieber, Maria José Juan-Fita, Yüksel Ürün, Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Ugo De Giorgi, Jakub Kucharz, Esther Pérez Calabuig, Vincenza Conteduca, Tarek Taha, Tarek Taha, Pasquale Rescigno, Hussam Abu-Sini, Gian Paolo Spinelli, Ray Manneh Kopp, Alessia Salfi, Dipen Bhuva, Paola Valdez-Sandoval, Sofia Mendez-Bribiesca, Ondrej Fiala, Ondrej Fiala, Sebastiano Buti, Sebastiano Buti, Fernando Sabino Marques Monteiro, Fernando Sabino Marques Monteiro, Aristotelis Bamias, Marwan Ghosn, Francesco Massari, Francesco Massari, Jawaher Ansari, Matteo Santoni

Subjects: Get full text

Comparison of Prognostic Risk Models (IMDC, MSKCC, CFF) in Patients Diagnosed with Metastatic Renal Cell Cancer by Merve KESKİNKILIÇ, Kübra CANASLAN, Hüseyin Salih SEMİZ, Tuğba YAVUZŞEN

Subjects: Get full text